SH2 domain proteins as high-affinity receptor tyrosine kinase substrates.
SH2 domain proteins as high-affinity receptor tyrosine kinase substrates.
复制标题
SH2 结构域蛋白作为高亲和力受体酪氨酸激酶底物。
DOI:
10.1021/bi00089a028
复制
发表时间:
1993
期刊:
影响因子:
2.9
通讯作者:
Koland,JG
中科院分区:
文献类型:
--
作者:
Sierke,SL;Koland,JG
Revised Manuscript Received June 17, 1993* abstract: Activation of a growth factor receptor tyrosine kinase (RTK) is accompanied by a rapid autophosphorylation of the receptor on tyrosine residues. Receptor activation has been shown topromote the association of signal-transducing proteins containing SH2 domains (second domain of src homology). These receptor-associated proteins can, in turn, be phosphorylated by the RTK, an event which presumably regulates their activities. It has been suggested that SH2 domains in signal-transducing proteins target these proteins as substrates of the activated RTK. To test this hypothesis, recombinant proteins were generated that contained tyrosine phosphorylation sites of the erbB3 receptor and/or the SH2 domain of c-src. Incorporation of the SH2 domain led to a decrease in Km and an increase in VmiX for the substrate. The Km determined for one chimeric SH2/erbB3 substrate was among the lowest reported for epidermal growth factor RTK substrates. Experiments with a truncated kinase lackingC-terminal autophosphorylation sites indicated that the reduction in Km for these substrates was mediated by interactions between the substrate SH2 domain and phosphotyrosine residues of the RTK. These interactions could also inhibit RTK activity. These results demonstrate that the SH2 domain can effectively target substrates to a RTK and that SH2 domain proteins can regulate RTK activity.A variety of polypeptide growth factor receptors that possess intrinsic protein tyrosine kinase activity have now been characterized. These include the receptors for epidermal growth factor (EGF1), platelet-derived growth factor (PDGF) and insulin, and also certain protooncogene products, such as c-kit (the stem cell factor receptor) and c-fms (the macrophage colony-stimulating factor receptor)(Cadena &Gill, 1992; Yarden & Ullrich, 1988). The signal transduction pathways activated by these receptors are diverse and involve other